Vicapsys Life Sciences Stock Cash Flow From Operations
| VICP Stock | USD 7.00 0.00 0.00% |
Vicapsys Life Sciences fundamentals help investors to digest information that contributes to Vicapsys Life's financial success or failures. It also enables traders to predict the movement of Vicapsys Pink Sheet. The fundamental analysis module provides a way to measure Vicapsys Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vicapsys Life pink sheet.
Vicapsys |
Vicapsys Life Sciences Company Cash Flow From Operations Analysis
Vicapsys Life's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Vicapsys Life Cash Flow From Operations | (262.9 K) |
Most of Vicapsys Life's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vicapsys Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Vicapsys Life Sciences has (262,897) in Cash Flow From Operations. This is 100.05% lower than that of the Healthcare sector and 100.42% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 100.03% higher than that of the company.
Vicapsys Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vicapsys Life's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vicapsys Life could also be used in its relative valuation, which is a method of valuing Vicapsys Life by comparing valuation metrics of similar companies.Vicapsys Life is currently under evaluation in cash flow from operations category among its peers.
Vicapsys Fundamentals
| Return On Equity | -10.59 | |||
| Return On Asset | -0.8 | |||
| Current Valuation | 31.17 M | |||
| Shares Outstanding | 31.19 M | |||
| Shares Owned By Insiders | 45.87 % | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0 X | |||
| EBITDA | (734.42 K) | |||
| Net Income | (765.84 K) | |||
| Cash And Equivalents | 17.29 K | |||
| Debt To Equity | 285.70 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (262.9 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | -4.44 | |||
| Market Capitalization | 31.19 M | |||
| Total Asset | 404.12 K | |||
| Z Score | -3.3 | |||
| Net Asset | 404.12 K |
About Vicapsys Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vicapsys Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vicapsys Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vicapsys Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vicapsys Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vicapsys Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicapsys Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Vicapsys Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vicapsys Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vicapsys Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vicapsys Life Sciences to buy it.
The correlation of Vicapsys Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vicapsys Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vicapsys Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vicapsys Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vicapsys Pink Sheet Analysis
When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.